BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 30103323)

  • 1. Early Impairments of Hippocampal Neurogenesis in 5xFAD Mouse Model of Alzheimer's Disease Are Associated with Altered Expression of SOXB Transcription Factors.
    Zaletel I; Schwirtlich M; Perović M; Jovanović M; Stevanović M; Kanazir S; Puškaš N
    J Alzheimers Dis; 2018; 65(3):963-976. PubMed ID: 30103323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippocampal neurogenesis in the APP/PS1/nestin-GFP triple transgenic mouse model of Alzheimer's disease.
    Zeng Q; Zheng M; Zhang T; He G
    Neuroscience; 2016 Feb; 314():64-74. PubMed ID: 26639620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer's disease and has therapeutic implications for neurocognitive disorders.
    Kiyota T; Ingraham KL; Jacobsen MT; Xiong H; Ikezu T
    Proc Natl Acad Sci U S A; 2011 Dec; 108(49):E1339-48. PubMed ID: 22042871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuron and neuroblast numbers and cytogenesis in the dentate gyrus of aged APP
    Olesen LØ; Sivasaravanaparan M; Severino M; Babcock AA; Bouzinova EV; West MJ; Wiborg O; Finsen B
    Neurobiol Dis; 2017 Aug; 104():50-60. PubMed ID: 28461249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired hippocampal neurogenesis and its enhancement with ghrelin in 5XFAD mice.
    Moon M; Cha MY; Mook-Jung I
    J Alzheimers Dis; 2014; 41(1):233-41. PubMed ID: 24583405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer's disease.
    Zhang C; McNeil E; Dressler L; Siman R
    Exp Neurol; 2007 Mar; 204(1):77-87. PubMed ID: 17070803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual roles of Aβ in proliferative processes in an amyloidogenic model of Alzheimer's disease.
    Baglietto-Vargas D; Sánchez-Mejias E; Navarro V; Jimenez S; Trujillo-Estrada L; Gómez-Arboledas A; Sánchez-Mico M; Sánchez-Varo R; Vizuete M; Dávila JC; García-Verdugo JM; Vitorica J; Gutierrez A
    Sci Rep; 2017 Aug; 7(1):10085. PubMed ID: 28855626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep Brain Magnetic Stimulation Promotes Neurogenesis and Restores Cholinergic Activity in a Transgenic Mouse Model of Alzheimer's Disease.
    Zhen J; Qian Y; Fu J; Su R; An H; Wang W; Zheng Y; Wang X
    Front Neural Circuits; 2017; 11():48. PubMed ID: 28713248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased hippocampal neurogenesis in the progressive stage of Alzheimer's disease phenotype in an APP/PS1 double transgenic mouse model.
    Yu Y; He J; Zhang Y; Luo H; Zhu S; Yang Y; Zhao T; Wu J; Huang Y; Kong J; Tan Q; Li XM
    Hippocampus; 2009 Dec; 19(12):1247-53. PubMed ID: 19309037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osthole Upregulates BDNF to Enhance Adult Hippocampal Neurogenesis in APP/PS1 Transgenic Mice.
    Liu H; Xue X; Shi H; Qi L; Gong D
    Biol Pharm Bull; 2015; 38(10):1439-49. PubMed ID: 26424009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATG5 (autophagy related 5) in microglia controls hippocampal neurogenesis in Alzheimer disease.
    Tang X; Walter E; Wohleb E; Fan Y; Wang C
    Autophagy; 2024 Apr; 20(4):847-862. PubMed ID: 37915255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Changes in Hippocampal Neurogenesis in Transgenic Mouse Models for Alzheimer's Disease.
    Unger MS; Marschallinger J; Kaindl J; Höfling C; Rossner S; Heneka MT; Van der Linden A; Aigner L
    Mol Neurobiol; 2016 Oct; 53(8):5796-806. PubMed ID: 27544234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomere shortening reduces Alzheimer's disease amyloid pathology in mice.
    Rolyan H; Scheffold A; Heinrich A; Begus-Nahrmann Y; Langkopf BH; Hölter SM; Vogt-Weisenhorn DM; Liss B; Wurst W; Lie DC; Thal DR; Biber K; Rudolph KL
    Brain; 2011 Jul; 134(Pt 7):2044-56. PubMed ID: 21672962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
    Wu Y; Gong Y; Luan Y; Li Y; Liu J; Yue Z; Yuan B; Sun J; Xie C; Li L; Zhen J; Jin X; Zheng Y; Wang X; Xie L; Wang W
    FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrahydrohyperforin increases adult hippocampal neurogenesis in wild-type and APPswe/PS1ΔE9 mice.
    Abbott AC; Calderon Toledo C; Aranguiz FC; Inestrosa NC; Varela-Nallar L
    J Alzheimers Dis; 2013; 34(4):873-85. PubMed ID: 23302657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental enrichment reverses Aβ pathology during pregnancy in a mouse model of Alzheimer's disease.
    Ziegler-Waldkirch S; Marksteiner K; Stoll J; d'Errico P; Friesen M; Eiler D; Neudel L; Sturn V; Opper I; Datta M; Prinz M; Meyer-Luehmann M
    Acta Neuropathol Commun; 2018 May; 6(1):44. PubMed ID: 29855361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease.
    Donovan MH; Yazdani U; Norris RD; Games D; German DC; Eisch AJ
    J Comp Neurol; 2006 Mar; 495(1):70-83. PubMed ID: 16432899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired neurogenesis is an early event in the etiology of familial Alzheimer's disease in transgenic mice.
    Demars M; Hu YS; Gadadhar A; Lazarov O
    J Neurosci Res; 2010 Aug; 88(10):2103-17. PubMed ID: 20209626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral dopamine neurotrophic factor improves long-term memory in APP/PS1 transgenic mice modeling Alzheimer's disease as well as in wild-type mice.
    Kemppainen S; Lindholm P; Galli E; Lahtinen HM; Koivisto H; Hämäläinen E; Saarma M; Tanila H
    Behav Brain Res; 2015 Sep; 291():1-11. PubMed ID: 25975173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noggin and BMP4 co-modulate adult hippocampal neurogenesis in the APP(swe)/PS1(DeltaE9) transgenic mouse model of Alzheimer's disease.
    Tang J; Song M; Wang Y; Fan X; Xu H; Bai Y
    Biochem Biophys Res Commun; 2009 Jul; 385(3):341-5. PubMed ID: 19463786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.